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Introduction
Postoperative venous thromboembolism (VTE) is not rare. Its incidence was evaluated at 1% in 2000 [1] . The consequences can be severe, with an estimated rate of mortality for pulmonary embolism of 5-25% [2, 3] . It also results in extended length of stay, induced morbidity (i.e. anticoagulant drug iatrogeny), and increased costs [1] .
Many factors have been found to be associated with VTE risk: the existence of a prior event, cancer, prolonged immobility, or surgical intervention [4] . Among the surgical interventions, lower limb arthroplasty and major general surgery are associated with a sufficient risk to justify drug prophylaxis [5] .
The risk associated with spinal surgery is not precisely known. Glotzbecker estimated it to be between 1% and 31% in a recent review [6] . Only two population-based studies estimating the incidence of VTE after spinal surgery have been published, in 2010 and 2014, which reported event rates of 1.00% and 1.37%, respectively [7, 8] . Similarly, there are only a few studies on the role of thromboprophylaxis, and these have shown minimal benefit of pharmacological prophylaxis [6, 9] . Thus, guidelines regarding prophylaxis for the prevention of thromboembolism after spinal surgery are poor and not sufficiently substantiated. The American College of Chest Physicians and the European Society of Anaesthesiology suggest pharmacological prophylaxis in cases in which there is a high VTE risk and a decreased bleeding risk (grade 2C) [10, 11] .
The recent development of surgical techniques, approaches and devices has led to a continuous increase in the number of spine surgeries in developed countries [12] . This is particularly true for lumbar arthrodesis, with a 2.4-fold increase in the USA between 2000 and 2009 [13] . To our knowledge, no study has yet explored the role of devices and surgical approach in thromboembolism risk in patients undergoing lumbar spine surgery (LBS).
The aims of this study were to estimate the incidence of thromboembolism in France after LBS, and to identify risk factors among the surgical characteristics.
Materials and methods
We conducted a cohort study of adult patients undergoing LBS in France between 2009 and 2014.
Source
Patients were identified in the French national health insurance scheme database (SNIIRAM) linked to the French hospital discharge database (Programme de M edicalisation des Syst emes d'Information [PMSI]) by their unique anonymous number. This study is based on the general national health insurance scheme for employees, representing 77% of the population (other schemes showed missing data). The SNIIRAM contains data concerning reimbursed medical care or products, including outpatient drugs, medical devices, and medical procedures. It also contains the type and the start date of the long-term disease, when it results in 100% reimbursement of care, according to the International Statistical Classification of Diseases, 10th Revision (ICD-10). The PMSI provides detailed information on medical diagnoses and surgical procedures during the hospital stay. These databases have been widely used in various pharmacoepidemiological studies [14] , including the assessment of several surgical procedures [15] [16] [17] [18] and VTE risk [19] .
Patients
Patients aged ≥18 years who underwent spine surgery between 1 January 2009 and 31 December 2014 were selected by use of the procedure codes from the French common classification of medical procedures (Table S1 ). In the event of repeated spinal procedures for the same patient during the study period, only the first surgery was included.
The exclusion criteria were as follows:
• Recent VTE (hospital admission for VTE in the year before inclusion), to avoid non-incident events
• Surgical intervention of any kind in the previous 6 months
• Multiple surgeries during the same hospital stay, to avoid confusion between various surgical risks A second step combining the procedure's codes and ICD-10 codes made it possible to select patients who underwent LBS. Patients were included if they had: (i) a code for a lumbar spine procedure; or (ii) a code for spinal surgery and a diagnostic ICD-10 code for a lumbar spine disease.
Data collected
Outcome The primary outcome was the occurrence of VTE during the year following surgery. This was assessed by the use of hospital discharge records citing either pulmonary embolism or lower-limb venous thrombosis (ICD-10 codes I26 or I800-803; distal and proximal thrombosis were considered together, owing to the lack of precise information in the database; moreover, incidental VTE could not be distinguished from clinical VTE).
The date of the event was defined either as the date of the related diagnostic examination, or as the date of the new hospital admission in question. Where an event occurred during initial hospitalization and the date of diagnosis was missing, a date was attributed to four-fifths of the length of stay, which was the median time to occurrence of VTE in similar patients.
Risk factors
Patients' known risk factors for VTE were assessed by the use of hospital discharge records and long-term disease records since 2006 (Table S2) : age, gender, obesity, cancer, including active cancer (defined by ICD-10 codes, combined with active treatment), renal disease, chronic pulmonary disease, high blood pressure (HBP), cardiovascular disease, psychiatric disease, severe paralysis, and other severe neurological disorders. The use of painkillers, antidepressants and oral contraceptives during the 3 months prior to surgery was also assessed.
Surgical factors were accurately evaluated: type of surgical approach (either posterior, anterior, or combined: defined from procedure codes), the presence of at least one implanted surgical device, and the type and quantity of surgical devices implanted (pedicular screws, other osteosynthesis devices, intersomatic cage, and disc prosthesis); and indication for surgery, i.e. spinal deformity involving more than five vertebrae, and spinal fracture.
Finally, the role of prophylaxis was evaluated. It was defined as administration of standard or low molecular weight heparin in the 2 days or 5 days following discharge from hospital.
Statistical analysis
A survival analysis with the Cox proportional hazard model with a 5% threshold for statistical significance was performed. Patients were followed up from the date of surgery to 1 year after surgery. Censoring was performed in the event of death or admission for surgery (for any reason), to prevent any confusion with the thromboembolic risk associated with the new surgery. Multivariate analysis was performed by chronological-logical stepwise backward selection of variables in two steps. First, we included all patient-related variables, selecting the significant variables, and second, we included the surgical variables to be tested. Variables were retained if statistical significance was found (P < 0.05).
Drug delivery is only measurable for outpatients in the SNIIRAM. Thus, the impact of thromboembolic prophylaxis was evaluated in a homogeneous subgroup of lowrisk patients with measurable postoperative drug consumption and with no preoperative anticoagulant treatment, or any early thromboembolic event during initial hospitalization. In the same way, patients discharged from hospital > 7 days later or admitted for rehabilitation after discharge were excluded. Patients with a high risk of an event (active cancer, spinal fracture, previous history of VTE, surgery for spinal deformity, severe paralysis, and age > 75 years) were also excluded from this analysis, in order to build a homogeneous subgroup with a low VTE risk, for whom there is significant doubt concerning the need for preventive treatment.
A Fine-Gray model was used to evaluate the potential misestimation attributable to competing risk. A sensitivity analysis was performed with pulmonary embolism as outcome. Analyses were performed with STATA 14.
Results

Patients
Of 477 024 patients screened, 323 737 (166 260 men, 51%) were included ( Table 1 ). The study selection process is shown in Fig. 1 . The mean age was 52.9 years. A majority of patients were operated on with a posterior approach (312 950, 97%) and surgical devices were implanted in 76 911 patients (24%). The mean length of stay was 5.8 days (standard deviation: 4.1 days).
Events
We observed 2942 events (0.91%): 1911 cases of deep vein thrombosis (DVT) of the lower limb, 816 cases of pulmonary embolism, and 215 combined events.
Censored patients included 49 184 with new surgical interventions and 2400 who died without VTE being mentioned. Among the 2608 deceased patients, 208 died following VTE, representing 7.1% of patients having experienced an event (versus 0.8% of patients not having experienced an event, P < 0.001).
Most (1913, 65%) of the events occurred within the first month (median, 12 days; Q1-Q3, 5-72), and more than half (1574, 54%) occurred during the initial stay. A survival curve is shown in Fig. 2 .
Risk factors for postoperative VTE
Patient-related factors associated with an increased risk were age, previous history of VTE, cancer, cardiovascular or respiratory disease, HBP, diabetes, obesity, renal disease, paralysis, and psychiatric disease. All surgical factors studied were also associated with VTE risk ( Table 2) .
The multivariate analysis (Table 3; Table S3 ) showed associations with nine patient-related variables: age 1-1.32) , and the use of oral antidepressants or contraceptives. Regarding surgical procedure, the risk was increased in the event of surgery for scoliosis (HR 3.61, 95% CI 2.96-4.4), the implantation of pedicular screws with a 'dose-effect' association (40% increased risk for 1-5 screws, 69% increased risk for 6-9 screws, and 117% increased risk for > 10 screws), and in the event of an anterior approach (HR 1.97, 95% CI 1.6-2.43) or a combined approach (HR 2.03, 95% CI 1.44-2.84).
Stratified analysis by instrumentation status (instrumented versus non-instrumented surgery) revealed no major effect modification or confounding (Tables S4 and  S5 ). There were no significant changes in association estimates when a Fine-Gray model was used (not shown). The sensitivity analysis with pulmonary embolism produced similar results (Table S6) .
Role of VTE prophylaxis
The role of VTE prophylaxis was analysed in a subgroup of 188 713 patients, in which 356 events occurred (the flowchart of this study is shown in Fig. S1 ). Totals of 35 391 (19%) and 2881 (1.5%) patients were found to have received heparin within 5 days and 2 days of discharge from hospital, respectively. Adjusted HRs associated with heparin prophylaxis ranged from 0.20 (all events, delivery within 2 days) to 0.89 (all events, delivery within 5 days), but the reduction in risk was not statistically significant, owing to a lack of power (Table S7) . A stratified analysis by instrumentation status was uninformative, owing to a lack of power.
Discussion
In this real-life national cohort study, the incidence of thromboembolic events after LBS was found to be 0.91% at 1 year, with an increased risk in the event of implanted surgical devices, and complex surgery or an anterior approach. These findings were stable across the assessments of VTE, and were strengthened by multiple adjustments.
Previous studies have only incompletely evaluated thromboembolic risk after spinal surgery. Most of them were case series with various types of surgical procedures, prophylactic measures, and methods for event diagnosis. This has resulted in a wide range of observed incidence rates. In the absence of pharmaceutical prophylaxis, Yoshioka et al. showed an incidence of 8.3% in a cohort of patients undergoing surgery with systematic DVT screening, whereas Nicol et al. showed a 0.29% incidence of symptomatic events in a Scottish register after elective lumbar surgery [20, 21] . The results of population-based studies are more relevant for comparison with the present study. In two surgical declarative national registers, dedicated to postoperative followup and assessment of complications (American College of Surgeon and Scoliosis Research Society), the authors observed a similar incidence of 1% VTE after spinal surgery [7, 22] . Finally, in the most similar study in terms of methods, Schairer et al. found a VTE incidence of 1.37% after spinal surgery in a bi-regional study in the USA [8] . The findings of these three studies are close to those of the present study, and classify spinal surgery as having a medium risk, in contrast to the high risk associated with lower-limb arthroplasty and some neurosurgical procedures [23] .
This study found early occurrence of VTE, with a median time to onset of 12 days. Bohl et al. and De la Garza Ramos et al. obtained similar results, with medians of 5 days and 4 days for pulmonary embolism, and 10.5 days and 12 days for DVT, respectively [24, 25] . This is also close to other observations made for orthopedic surgery: a median of 3 days for pulmonary embolism after lower-limb arthroplasty, and 50% of thromboembolic events in the first 7 days after total shoulder arthroplasty [26, 27] .
Two categories of independent risk factors for VTE were specified in this study.
First, several patient-related risk factors that have been widely studied and published were confirmed. Age, gender, immobility and palsy have been identified as major risk factors in both non-operated and operated patients [4, 28, 29] . The presence of cancer is known to increase VTE risk by up to 12-fold [30, 31] . A previous history of VTE was an independent risk factor after elective lowerlimb surgery in a study by Fuji et al., or after elective cranial surgery in a study by Smith et al. [32, 33] . Cardiac failure, respiratory disorders and renal diseases have been associated with an increased VTE risk after hip or knee arthroplasty [5, 28] . Renal diseases (mostly with impaired renal function) may also have prevented the use of low molecular weight heparins which are contraindicated in this context. Diabetes mellitus has less impact. Zhang et al. observed no association after lower-limb arthroplasty, whereas Dattani et al. found an increase in VTE in diabetic patients after shoulder surgery [28, 34] . Obesity is a limited risk factor, with a weight-size effect [4, 35] . Finally, psychiatric illness and, particularly, bipolar disorders or schizophrenia are known risk factors for VTE, with an increased risk in the event of antipsychotic treatment [36, 37] . The authors explain this association by a Time from surgery (months)
Survival without event © 2018 International Society on Thrombosis and Haemostasis combination of biological effects (hyperprolactinemia and antiphospholipid syndrome) and behavioral modifications, with reduced locomotion and dynamism [38] . There is no evidence in the literature on the association between VTE and antidepressant drugs. In the context of this study, it is highly likely that those treatments were given partly to treat pain in disabled patients, inducing confusion and restricted mobility. Our study showed that all of these risk factors are independently associated with a higher risk of postoperative VTE, with strong associations in the event of previous VTE, in relation to age, and in the presence of cancer. Second, this study shows evidence of a clear and 'doseresponse' association between VTE risk and the level of invasiveness of the surgery, reflected by the number of surgical devices. Implantation of any surgical devices carries a VTE risk of 67%, and a strong 'dose-effect' relationship was found for implanted pedicular screws. Pedicular screws are the most commonly used implants for osteosynthesis of the spine, and one or two are implanted per vertebra. Their number accurately represents the number of vertebrae operated on, as well as the surgical complexity. Similarly, patients operated on for long spinal deformities were found to have an independent, more than three-fold increased VTE risk. Such relationships with VTE had already observed by Schairer et al. in 2014 [8] . These authors showed an increase in VTE risk in cases with an increased number of vertebrae involved in spinal fusion, and a higher VTE risk in the event of implant-related complications. Finally, a twofold increased VTE risk was found in the event of an anterior approach in LBS. The risk of blood vessel injury during such procedures has been described; however, only a few studies have shown an increased VTE risk [39, 40] . Villavicencio et al. observed a higher risk of pulmonary embolism after anterior lumbar fusion (versus posterior), whereas Qureshi et al. found an increased DVT risk with an anterior versus a posterior approach [41, 42] .
Finally, we observed that 7% of patients died after the occurrence of an event. No information was available on the causes of death, but the incidence of fatal VTE has already been evaluated as being similar to or higher than this [2, 3] (this rate is probably substantially underestimated, as indicated by a recent autopsy study [43] ). The main strength of this study is the comprehensiveness and representativeness of the database, recording the real-life treatment of almost 80% of the patients undergoing spinal surgery in France. A further strength concerns the discharge diagnoses and procedure codes that are used to calculate payments for inpatient care, which are subject to both internal and external quality control procedures. The number of patients enabled us to apply rigorous rules for inclusion, in order to avoid confounding bias resulting from other medical events. Detailed data were used to specifically explore the impact of surgical procedures and implants adjusted on patient-related variables. Finally, the nature of the database containing systematic local recordings allowed us to conduct a 'real-life study' with independent assessment of the data.
However, this study had several limitations. First, the SNIIRAM is a medical and administrative database, in which the information recorded is used to pay care providers. Thus, there is a potential for misclassification of exposures and outcomes. In particular, it is possible that both coding procedures and medical events during hospitalizations had been affected by economic constraints (that is, there is a incentive to use the codes generating the most income). Thus, we chose to group patients in broad surgical categories (which prevented us from making an accurate analysis of the various posterior procedures). Second, we had no information on mechanical prophylaxis and drug consumption during the hospital stays. This prevented accurate analysis of the impact of drug prophylaxis for all patients. Our subgroup analysis had too little power to show a preventive effect.
In conclusion, this real-life national study showed a VTE risk of 1% after LBS. This risk is medium and is widely modulated by several easily identifiable risk factors (age, obesity, previous VTE, active cancer, paralysis, renal or psychiatric disease, use of antidepressant or contraceptive drugs, vertebral fracture, implantation of surgical devices, and surgery for spine deformity with the anterior approach). The surgical community should be aware of this heterogeneity, and adapt prevention according to patients and to the procedure, reducing avoidable risk factors (obesity, and use of antidepressants and contraceptive drugs) and using drug prophylaxis in the event of a high risk being present. A 3% cut-off is frequently used in orthopedics, and could be adopted to decide on whether or not prophylaxis should be given. However, randomized controlled trials are necessary to further document its efficiency, especially in low-risk cases.
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